Risk factors that affect our business and financial results are discussed within Part I, Item 1A of our Fiscal 2025 Form 10-K. There have been no material changes to our risk factors as disclosed in the Fiscal 2025 Form 10-K. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES Issuer Purchases of Equity Securities The following table provides information regarding our repurchases of our common stock during the 13 weeks ended May 2, 2026: Total Total Number of Maximum Number of Number of Average Shares Purchased as Shares that May Shares Price Paid Part of Publicly Yet Be Purchased Period Purchased Per Share Announced Programs Under the Program (1) (2) (1) (1) (3) Month #1 (February 1, 2026 through February 28, 2026) 494,227 $ 23.09 — 49,084,301 Month #2 (March 1, 2026 through April 4, 2026) 3,515,128 17.64 3,000,000 46,084,301 Month #3 (April 5, 2026 through May 2, 2026) 3,262 17.70 — 46,084,301 Total 4,012,617 $ 18.31 3,000,000 46,084,301 (1)There were 3.0 million shares repurchased as part of our publicly announced share repurchase program, and an aggregate of 1.0 million shares were repurchased for the payment of taxes in connection with the vesting of share-based payments during the 13 weeks ended May 2, 2026. (2)Average price paid per share excludes any broker commissions paid. (3)On March 11, 2025, the Board authorized the public repurchase of an additional 50 million shares under our existing share repurchase program, which expires on February 3, 2029.